Demo Sign up Log In

Gilead Sciences (GILD)

Cash & Equivalents

$3.18B

Quarterly · Period ending: Jun 30, 2026 · USD

GILD Cash & Equivalents

Latest reported$3.18Bperiod endingJun 30, 2026

Latest reported$3.18Bperiod endingJun 30, 2026

GILD Quarterly Cash & Equivalents ($10.30M → $3.18B)

Quarterly Cash & Equivalents

High-resolution chart · PNG

GILD cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gilead Sciences Cash & Equivalents — Quarterly (USD)
Period ending	Cash & Equivalents (USD)
Jun 30, 2001	46,921,000
Mar 31, 2001	77,403,000
Dec 31, 2000	197,292,000
Sep 30, 2000	43,374,000
Jun 30, 2000	42,740,000
Mar 31, 2000	37,296,000
Dec 31, 1999	47,011,000
Sep 30, 1999	70,800,000
Jun 30, 1999	45,300,000
Mar 31, 1999	58,400,000
Dec 31, 1998	101,100,000
Sep 30, 1998	43,200,000
Jun 30, 1998	37,000,000
Mar 31, 1998	34,300,000
Dec 31, 1997	32,000,000
Sep 30, 1997	45,700,000
Jun 30, 1997	139,000,000
Mar 31, 1997	104,700,000
Dec 31, 1996	132,000,000
Sep 30, 1996	156,000,000
May 31, 1996	182,900,000
Mar 31, 1996	49,400,000
Sep 30, 1995	72,400,000
Jun 30, 1995	8,500,000
Mar 31, 1995	30,400,000
Dec 31, 1994	15,300,000
Sep 30, 1994	26,600,000
Jun 30, 1994	43,700,000
Mar 31, 1994	13,000,000
Dec 31, 1993	8,600,000
Sep 30, 1993	2,100,000
Jun 30, 1993	3,500,000
Mar 31, 1993	2,100,000
Dec 31, 1992	47,800,000
Sep 30, 1992	2,300,000
Jun 30, 1992	17,900,000
Mar 31, 1992	87,900,000
Mar 31, 1991	10,300,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.